Clinical study on Fu's Subcutaneous Needling (FSN)’s for treatment of qi stagnation type of breast pain

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003203

Enrollment

Unknown

Registered

2013-05-02

Start date

2013-05-14

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast pain

Interventions

FSN:FSN

Electric acupuncture:acupuncture+Electric acupuncture

Proprietary Chinese medicine Group:Oral prunella oral liquid

Vitamin E Group:Oral prunella oral liquid

Eligibility

Sex/Gender

Female

Age

30 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with qi stagnation type of breast pain who can cooperate with the research; 2. Aged 30-45 years old women, informed consent; 3. Menstrual cycle is normal: 28 plus or minus 7 days.

Exclusion criteria

Exclusion criteria: 1. Adenomatous hyperplasia,breast cancer,Breast fibroadenoma,and so on; 2. Combination of cardiovascular, liver and kidney and hematopoietic system and other serious diseases and psychiatric patients; 3. Pregnancy and nursing mothers; 4. Male or children who suffer this diseases; 5. Not in accordance with stipulations, unable to judge the effect, or the data is not complete; 6. Abnormal menstrual cycle; (7)mammographic show microcalcification point.

Design outcomes

Primary

Measure	Time frame
Short form McGill pain questionnaire;type-B ultrasonic;mammographic;Serum levels of sex hormone;	—

Countries

China

Contacts

Public ContactXia Youbing

xyb@njmu.edu.cn+86 13505199706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026